NATCO Pharma receives one observation after US FDA inspection at Mekaguda API facility
NATCO Pharma Limited has announced the successful conclusion of a routine inspection by the U.S. Food and Drug Administration (US FDA) at its Active Pharmaceutical Ingredients (API) manufacturing facility in Mekaguda, Hyderabad.
The inspection was conducted over a five-day period from June 9 to June 13, 2025. Upon conclusion, NATCO received only one observation in the Form 483 issued by the US FDA. According to the company, the observation is procedural in nature, and it is confident in addressing it comprehensively and in a timely manner.
In the excahgne filings, the company shared, 'The U.S. Food and Drug Administration (FDA) had conducted an inspection at the API manufacturing plant located in Mekaguda, Hyderabad, India, which was conducted from June 9th – June 13th, 2025. On conclusion of the inspection, the Company received 1 (One) observation in the Form-483. The Company believes that the observation is procedural in nature. The Company is confident to address this observation comprehensively.'
NATCO emphasized its ongoing commitment to current Good Manufacturing Practices (cGMP) and assured stakeholders of its continued focus on producing high-quality pharmaceutical products for global markets.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Vardhman Textiles executes agreement for 11.5 MW Wind-Solar Hybrid project in Madhya Pradesh
By Aman Shukla Published on June 14, 2025, 10:34 IST Vardhman Textiles Limited, one of India's leading textile manufacturers, announced a key update regarding its renewable energy initiative in Madhya Pradesh. The company has executed an Amended Share Subscription and Shareholders' Agreement with Renew Green Energy Solutions Private Limited and Renew Green (MPR One) Private Limited for its 11.5 MW Wind-Solar Hybrid Power Plant project. This development follows the earlier announcement dated May 2, 2023, wherein Vardhman Textiles disclosed its participation in a joint agreement to establish a captive power plant under the Captive Rules framework. The plant aims to generate clean energy exclusively for the company's use, aligning with its long-term sustainability and cost-efficiency goals. Under the amended agreement approved by the Committee of Directors (Renewable Energy) on June 14, 2025, the location of the renewable energy project has been changed— within the state of Madhya Pradesh . The specific new site has not been disclosed but is expected to offer logistical and operational advantages. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
an hour ago
- Business Upturn
Nifty 50 top gainers this week (June 14): Tech Mahindra, ONGC, Wipro, HCL Technologies, Grasim Industries and more
By Aman Shukla Published on June 14, 2025, 09:56 IST The Indian stock market closed lower on Friday, June 13, 2025, amid weak global cues and a surge in Brent crude oil prices following reports of a geopolitical escalation in the Middle East. The benchmark indices ended the session in the red, reflecting cautious investor sentiment. The Nifty 50 index declined by 169.60 points or 0.68% to close at 24,718.60, while the BSE Sensex fell by 573.38 points or 0.70% to settle at 81,118.60. The Nifty Bank index also came under pressure, shedding 555.20 points or 0.99% to close at 55,527.35. On a weekly basis, the Nifty 50 slipped by 284.45 points or 1.13%, while the Sensex registered a decline of 1,070.39 points or 1.30%. Several Nifty 50 stocks posted impressive weekly gains, with Tech Mahindra, ONGC and Wipro leading the charge. Let's take a look at the top gainers of Nifty 50 this week, as per Trendlyne data. Top Stock Gainers This Week (Ending June 14, 2025) Tech Mahindra closed at ₹1,659.00, up 5.6% for the week. Oil and Natural Gas Corporation (ONGC) ended at ₹251.50, registering a 4.8% weekly gain. Wipro closed at ₹260.20, up 4.7% for the week. HCL Technologies settled at ₹1,695.30, rising 3.5% over the week. Grasim Industries ended at ₹2,663.80, also posting a 3.5% increase. Dr. Reddy's Laboratories closed at ₹1,362.50, gaining 3.2% during the week. Infosys ended at ₹1,602.00, up 2.4% for the week. Tata Consultancy Services (TCS) closed at ₹3,445.70, with a 1.8% weekly rise. Kotak Mahindra Bank ended at ₹2,107.40, gaining 1.6% over the week. Hero MotoCorp closed at ₹4,333.80, up 1.5% for the week. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Grasim IndustriesHCL TechnologiesNiftyONGCTech MahindraWipro Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
an hour ago
- Business Upturn
Sun Pharma's Halol facility receives form 483 with 8 observations from US FDA
By Aman Shukla Published on June 14, 2025, 09:42 IST Sun Pharmaceutical Industries Limited, one of India's leading pharmaceutical companies, has announced the conclusion of a recent inspection by the United States Food and Drug Administration (US FDA) at its Halol manufacturing facility located in Gujarat, India. The inspection was conducted from June 2 to June 13, 2025, as part of the regulatory authority's routine evaluation of current Good Manufacturing Practices (GMP) compliance. At the end of the inspection, the US FDA issued a Form 483 to the company, outlining eight observations. In a regulatory filing, Sun Pharma stated: 'We hereby inform that the US FDA conducted a GMP inspection of our Halol facility from 02 June to 13 June 2025. At the conclusion of the inspection, the US FDA issued a Form-483 with 8 observations.' A Form 483 is issued by the US FDA when its investigators observe any conditions that may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related regulations. These observations are based on conditions found during routine inspections and are intended to prompt the company to take corrective actions. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
